Why Japan is different
Japan’s longevity-supplement market developed earlier and more thoroughly than anywhere else, supported by domestic manufacturers, a strong retail pharmacy channel and a consumer base already accustomed to functional foods.
NMN in particular has been available at scale in Japan while other markets were still arguing about its category. The result is a buyer population that is unusually well informed — and correspondingly harder to impress with vague claims.
The labelling systems
Japan operates several parallel frameworks. FOSHU (Foods for Specified Health Uses) requires product-specific clinical substantiation and government approval. Foods with Function Claims (機能性表示食品) allows a manufacturer to notify a claim supported by published evidence without full pre-approval. Foods with Nutrient Function Claims covers established vitamins and minerals.
The practical effect is that Japanese labels often carry more specific and better-substantiated claims than equivalents elsewhere, and buyers read them expecting that specificity.
What Japanese buyers ask
The question order differs noticeably from Western markets. Provenance first — where is the strain from, who did the research, where is it manufactured. Evidence second — what method, what was measured, is it published. Format third — stability, dosing precision, whether it fits a daily routine. Price last.
This suits a documentation-first product. The answers here are: a strain recovered from Yakutian permafrost, research led by Prof. Anatoli Brouchkov at Moscow State University, comet-assay imaging as the reference method, patent WO2012060729 plus five national patents — all published openly rather than summarised.
Postbiotics in a Japanese context
Japan has a long and mainstream relationship with fermented foods and their derived compounds — natto, miso, koji, shio-koji. The concept of a beneficial fermentation-derived metabolite requires no explanation here; it is culturally ordinary.
That makes the postbiotic distinction easier to convey than in markets where "bacteria in a bottle" is the default mental model. The relevant point for a Japanese buyer is usually the stability advantage: no refrigeration, no viability decline, consistent dose across a long protocol.
Ordering from Japan
We ship to Japan. The process is the same as everywhere: send a request stating your country, receive a written reply within 48 hours confirming availability and price, then an invoice from our Estonian entity.
The site is available in Japanese — every page, including the documentation descriptions, is maintained in 日本語 alongside English. Order correspondence is currently handled in English.